scholarly journals Case report of a rare urinary bladder tumor variant (carcinosarcoma)

2020 ◽  
Vol 12 (2) ◽  
pp. 190
Author(s):  
HatemHamed Althubiany ◽  
RamiMohammad Hasan ◽  
SaeedAbdullah Alzahrani ◽  
Salem Bahdilh
2002 ◽  
Author(s):  
Tatsuya Nakatani ◽  
Kazunobu Sugimura ◽  
Toshihide Naganuma ◽  
Sadanori Kamikawa ◽  
Toshikado Sugimoto

2020 ◽  
Author(s):  
Nadia Espejo-Herrera ◽  
Enric Condom Mundó

Abstract Background: Yolk sac tumor is a germ cell neoplasm that arises predominantly in the gonads, but can also derive from somatic neoplasms in extragonadal locations. These cases have been denominated recently as “somatically derived Yolk sac tumors”, and have been documented in several locations, although reports from the urinary tract are scarce. To our knowledge, this is the first report of a Yolk sac tumor derived from urothelial carcinoma. Case presentation: We present a unique case of a 76-year-old man with a recurrent urinary bladder tumor, initially interpreted as a high grade urothelial carcinoma with glandular differentiation. In the recurrent tumor, diverse histological patterns were identified, including glandular, hepatoid and sarcomatoid. This tumor showed positivity for AFP, GLP3 and SALL4, and negativity for CK7 and EMA. Fluorescent in situ hybridization study showed a polysomic pattern of chromosome 12. All these findings led to the final diagnosis of a Yolk sac tumor derived from urothelial carcinoma. Conclusions: Somatically derived Yolk Sac tumors should be considered in the differential diagnosis of a high grade urothelial carcinoma, particularly when glandular and other unusual patterns are observed. Key words: Yolk sac tumor, somatically derived, urothelial carcinoma, urinary bladder, case report.


Planta Medica ◽  
2005 ◽  
Vol 71 (11) ◽  
pp. 1030-1035 ◽  
Author(s):  
Dimitris Skalkos ◽  
Nikolaos Stavropoulos ◽  
Ioannis Tsimaris ◽  
Eleni Gioti ◽  
Constantine Stalikas ◽  
...  

Urologiia ◽  
2018 ◽  
Vol 2_2018 ◽  
pp. 147-153 ◽  
Author(s):  
Yu.G. Alyaev Alyaev ◽  
L.M. Rapoport Rapoport ◽  
A.Z. Vinarov Vinarov ◽  
N.I. Sorokin Sorokin ◽  
A.M. Dymov Dymov ◽  
...  

1997 ◽  
Vol 25 (4) ◽  
pp. 239-245 ◽  
Author(s):  
Shigeru Sakano ◽  
Tomoyuki Shimabukuro ◽  
Yasukazu Ohmoto ◽  
Katsusuke Naito

2015 ◽  
Vol 22 (10) ◽  
pp. 1217-1221
Author(s):  
Muhammad Salman Zafar ◽  
Muhammad Asadullah ◽  
Usman Ahmad

In spite of the fact that inflammation has been regarded as a localized orgeneralized defensive component of the body to different types harmful stimuli, there hasbeen becoming confirmation of its strong part in initiation or progression of different ailmentsparticularly related with cancer. Objectives: Aim of this study was to recognize the pattern ofexpression and level of intensity of COX-2 in different grades of papillary urothelial carcinomaof urinary bladder along with significance of COX 2 in tumerogenesis of urothelial carcinoma ofurinary bladder. Setting: Department of Pathology, BMSI, JPMC. Period: 1.1.2009 to 31.12.2012.Methods: The marker of COX-2 was investigated by using Immuno- histochemistry. Results:COX 2 was not detected in normal urothelium, but its intensity was expressed as 68% in lowgrade, 72 % in high grade and 80 % in invasive urothelial carcinoma. Conclusion: Results ofthe present study indicate that COX-2 as a component of inflammation play an important rolein progression of urinary bladder tumor and encourage use of COX 2 inhibitors as potentialantitumor agent.


Sign in / Sign up

Export Citation Format

Share Document